Efficacy of Laser Therapy for Periodontitis
Launched by UNIVERSITY OF SCIENCE AND TECHNOLOGY, YEMEN · Jun 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a special type of laser treatment, called diode laser therapy, for patients with periodontitis, a serious gum disease. The researchers want to see how this laser therapy, when combined with standard periodontal treatment, can improve the health of the gums and reduce inflammation. They will also check how this treatment affects certain substances in the gums before and after the therapy.
To participate in this study, individuals need to be between 25 and 58 years old and have generalized periodontitis, which means their gums are significantly inflamed and bleeding. They should have at least 20 natural teeth. However, some people won't be eligible, such as smokers, pregnant or breastfeeding women, those taking certain medications, or anyone who has had recent dental treatments. If you qualify and choose to participate, you will receive additional care for your gum disease and help contribute valuable information to improve treatments for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Only patients meeting the following criteria will be enrolled into the study:
- • Patient with generalized periodontitis (BOP and PPD ≥ 4 mm).
- • Age group of 25-58 years old of periodontitis patients with at least 20 teeth present.
- Exclusion Criteria:
- • Smoker and qat chewer patients.
- • Pregnant and lactating women.
- • Patients take medications which might influence the periodontal tissue state.
- • Patients having systemic health disorders which affect the periodontium by history.
- • Patients who received periodontal treatment or antibiotic therapy 3 months before the study.
- VI. Patient wearing intra-oral appliance or with dental prosthesis. :
- • -
About University Of Science And Technology, Yemen
The University of Science and Technology (UST) in Yemen is a leading academic institution dedicated to advancing research and innovation in various scientific fields. With a strong emphasis on interdisciplinary collaboration, UST aims to enhance healthcare outcomes through rigorous clinical trials and research initiatives. The university is committed to ethical standards and the highest quality of scientific inquiry, fostering an environment that supports the development of effective medical interventions. By leveraging its academic expertise and resources, UST plays a pivotal role in addressing health challenges and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Waddah N Al-Hajj, Assoc prof
Study Chair
Faculty of dentistry -Thamar university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported